Familial frontal fibrosing alopecia - 17/06/15
Doi : 10.1016/j.jaad.2015.01.057
Christos Tziotzios, MA, MBBChir (Cantab), MRCP (UK), FHEA a, ⁎ 
, David A. Fenton, MBE, FRCP a, Catherine M. Stefanato, MD, FRCPath b, John A. McGrath, MD, FRCP, FMedSci a
, David A. Fenton, MBE, FRCP a, Catherine M. Stefanato, MD, FRCPath b, John A. McGrath, MD, FRCP, FMedSci a a St John's Institute of Dermatology, King's College London, Guy's Hospital, London, United Kingdom
b Dermatopathology, King's College London, Guy's Hospital, London, United Kingdom
∗Correspondence to: Dr Christos Tziotzios, MA, MBBChir (Cantab), MRCP (UK), FHEA, St John's Institute of Dermatology, 9th floor, Tower Wing, Guy's Hospital, London SE1 9RT, United Kingdom
Le texte complet de cet article est disponible en PDF.
| Funding sources: CT holds a National Institute for Health Research (NIHR) Fellowship and an honorary contract with the National Health Service (NHS). DAF and CMS are employed by the NHS. JAM is employed by King's College London and holds an honorary NHS contract with the host organization (Guy's and St Thomas' Hospitals NHS Foundation Trust). |
|
| Conflicts of interest: None declared. |
© 2015
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 73 - N° 1
P. e37 - juillet 2015 Retour au numéro
Article précédent
- Reply to: “Skin moisturization for xerosis related to targeted anticancer therapies”
- Johannah Valentine, Viswanath Reddy Belum, Juanita Duran, Kathryn Ciccolini, Katja Schindler, Shenhong Wu, Mario E. Lacouture
- HLA-DR1 in familial frontal fibrosing alopecia
- Derek V. Chan, Joseph Flynn, Rebecca Ziegler, Henry K. Wong
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?